BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 155 participants.
Also called NCT02228564
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 155 participants
- Sponsor
- Registry
-
NCT02228564
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT02228564. Allocation not applicable; no masking; primary purpose treatment. Start 2014-09 (registry gives no type); primary completion 2016-12 (actual). Results posted on 2020-10-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BARD® Study of LIFESTREAM™ Balloon Expandable Covered Stent Treating Iliac Arterial Occlusive Disease
- Acronym
- BOLSTER
- Condition
- Peripheral Artery Disease
- Condition
- Peripheral Vascular Disease
- Condition
- Arterial Occlusive Disease
- Intervention (Procedure)
- Percutaneous transluminal angioplasty (PTA)
- Intervention (Device)
- LIFESTREAM™ covered stent
- Lead sponsor
- C. R. Bard
Record details
- Record id
cardio:ct-nct02228564- Content hash
1429ae619683eaa29073eeba9d1d8b13bcaef1c36a722d2b2438126daeb1c996